(Q34599344)

English

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis (English)

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

Alexander J. Lazar

3

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

2

object named as

Kelly K Hunt

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

author name string

John C McAuliffe

1

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Haesun Choi

4

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Wei Qiao

5

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Peter Thall

6

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Raphael E Pollock

7

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Robert S Benjamin

8

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Jonathan C Trent

9

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

publication date

25 October 2008

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

16

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

910-919

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

copyright license

Creative Commons Attribution-NonCommercial 2.0 Generic

25 October 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1245/s10434-008-0177-7

0 references

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

The role of nitric oxide in mediating tumour blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Imatinib mesylate in the treatment of gastrointestinal stromal tumour

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

7 July 2018

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

26 October 2018

Endothelial cell KIT expression in human tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5647649

26 October 2018

Gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18953611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide pathway is induced by Fc epsilon RI and up-regulated by stem cell factor in mouse mast cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18953611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18953611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18953611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18953611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-008-0177-7

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

28 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34599344&oldid=1977404494"